Schroder Investment Management Group Charles River Laboratories International, Inc. Transaction History
Schroder Investment Management Group
- $101 Billion
- Q4 2024
A detailed history of Schroder Investment Management Group transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 2,472 shares of CRL stock, worth $372,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,472
Previous 2,472
-0.0%
Holding current value
$372,085
Previous $486,000
6.17%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
50MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$927 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$766 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$328 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$272 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$272 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.66B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...